Plain-English translation of NCT06630585 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a weekly injectable medication, can help improve blood sugar control when added to an automated insulin delivery system (insulin pump). The study will compare people who take alongside their regular pump therapy to people who continue with their pump alone. Researchers hope this medication will help keep blood sugar in a healthier range and reduce the amount of insulin needed.
Many adults with type 1 diabetes still struggle to reach their blood sugar goals, even with insulin pumps. Early studies suggest this medication might help lower blood sugar levels and reduce insulin doses, but doctors need a rigorous clinical trial to confirm whether it actually works and is safe.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either continue your regular insulin pump therapy alone, or add the weekly medication to your current routine. Over 16 weeks (4 weeks to gradually start the medication, then 12 weeks at the full dose), you'll wear a continuous glucose monitor to track your blood sugar throughout the day and night. You'll have regular study visits where researchers will check your blood sugar control, weight, and how you're feeling.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Switzerland